A Clinical Study to Investigate the Effects of Dapagliflozin on Heart Work, Heart Nutrient Uptake, and Heart Muscle Efficiency in Type 2 Diabetes Patients

NCT03387683 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

53

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus Type 2

Interventions

DRUG: dapagliflozin
DRUG: placebo

Sponsor

AstraZeneca